Misoprostol for cervical ripening and labor induction: The clinician's perspective and guide to success

Contemporary Ob-Gyn

Volumn 44, Issue 4, 1999, Pages 46-61

  Wing, Deborah A ^a   Paul, Richard H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24044532647     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Committee on Obstetrics. Induction of Labor. Washington DC: American College of Obstetricians and Gynecologists, 1995: American College of Obstetricians and Gynecologists, Technical Bulletin No. 217.
2. Ventura SJ, Martin JA, Curtin SC, et al. Report of final natality statistics, 1996. Mon Vital Stat Rep. 1998;Jun 30;46(11Suppl):1-99.
3. Blue Book first data bank 1996. New York: Hearst Corporation, 1995.
4. Sanchez-Ramos L, Kaunitz AM, Del Valle GO, et al. Labor induction with the prostaglandin E, methyl analogue misoprostol versus oxytocin: a randomized trial. Obstet Gynecol. 1993;81:332-336.
5. Fletcher H, Mitchell S, Frederick J, et al. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol. 1994;83:244-247.
6. Varaklis K, Gumina R, Stubblefield PG. Randomized controlled trial of vaginal misoprostol and intracervical prostaglandin E2 gel for induction of labor at term. Obstet Gynecol. 1995;86:541-544.
7. 2 gel (Prepidil gel): randomized comparison. Am J Obstet Gynecol. 1995;173:1137-1142.
8. Mundle WR, Young DC. Vaginal misoprostol for induction of labor: a randomized controlled trial. Obstet Gynecol. 1996;88:521-525.
9. 2 to induce labor. Am J Obstet Gynecol. 1997;177:1018-1023.
10. 2 gel for preinduction cervical ripening. Am J Obstet Gynecol. 1997;177:1067-1070.
11. Kramer RL, Gilson GJ, Morrison DS, et al. A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacy. Obstet Gynecol. 1997;89:387-391.
12. 2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1995;172:1804-1810.
13. Wing DA, Rahall A, Jones MM, et al. Misoprostol: an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol. 1995;172:1811-1816.
14. Wing DA, Ortiz-Omphroy G, Paul RH. A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol. 1997;177:612-618.
15. Sanchez-Ramos L, Peterson DE, Delke I, et al. Labor induction with prostaglandin E, misoprostol compared with dinoprostone vaginal insert: a randomized trial. Obstet Gynecol. 1998;91:401-405.
16. Wing DA, Paul RH. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1996;175:158-164.
17. Sanchez-Ramos L, Kaunitz AM, Wears RL, et al. Misoprostol for cervical ripening and labor induction: a meta-analysis. Obstet Gynecol. 1997;89:633-642.
18. Wing DA, Paul RH. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation. Am J Obstet Gynecol. 1998;179:94-99.
19. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol. 1998;91:828-830.
20. 1 analog misoprostol for labor induction. Am J Obstet Gynecol. 1997;177:364-371.
21. Sanchez-Ramos L, Chen AH, Kaunitz AM, et al. Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study. Obstet Gynecol. 1997;89:909-912.
22. Sciscione AC, Nguyen L, Manley JS, et al. Uterine rupture during preinduction cervical ripening with misoprostol in a patient with a previous cesarean delivery. Aust N Z J Obstet Gynecol. 1998;38:96-97.
23. Schwartz ML Uterine rupture associated with the use of misoprostol in the gravida with a prior cesarean section (Abstract). Proceedings of the Sixty-Fifth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, 1998.
24. 2 for cervical ripening and induction of labor in a community hospital (Abstract). Proceedings of the Sixty-Fifth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, 1998.
25. Bughalo A, Bique C, Machungo F, et al. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour. Gynecol Obstet Invest. 1995;39:252-256.
26. Carlan SJ, Bouldin S, O'Brien WF. Extemporaneous preparation of misoprostol gel for cervical ripening: a randomized trial. Obstet Gynecol. 1997;90:911-915.
27. Vengalil SR, Guinn DA, Olabi NF, et al. A randomized trial of misoprostol and extra-amniotic saline infusion for cervical ripening and labor induction. Am J Obstet Gynecol. 1998;91:774-779.
28. Perry KG, Larmon JE, May WL, et al. Cervical ripening: a randomized comparison between intravaginal misoprostol and an intracervical balloon catheter combined with intravaginal dinoprostone. Am J Obstet Gynecol. 1998;178:1333-1340.
29. Bennett BB. Uterine rupture during induction of labor at term with intravaginal misoprostol. Obstet Gynecol. 1997;89:832-833.
30. Ngai SW, To WK, Lao T, et al. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstet Gynecol. 1996;87:923-926.
31. Windrim R, Bennett K, Mundle W, et al. Oral administration of misoprostol for labor induction: a randomized controlled trial. Obstet Gynecol. 1997;89:392-397.
32. Toppozada MK, Anwar MY, Hassan HA, et al. Oral or vaginal misoprostol for induction of labor. Int J Gynaecol Obstet. 1997;56:135-139.
33. Wing DA, Ham D, Paul RH. A comparison of orally administered to vaginally administered misoprostol for cervical ripening and labor induction. Am J Obstet Gyn. In press.
34. Bennett KA, Butt K, Crane JM, et al. A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction. Obstet Gynecol. 1998;92:481-486.
35. Adair CD, Weeks JW, Barrilleaux S, et al. Oral or vaginal misoprostol administration for induction of labor: a randomized, double-blind trial. Obstet Gynecol. 1998;92:810-813.
36. Raybum WF, Farmer KC. Off-label prescribing during pregnancy. Obstet Gynecol Clin N Am. 1997;24:471-478.
37. Use of approved drugs for unlabeled indications. FDA Drug Bull. 1982:12:4-5.
38. Fletcher HM, Mitchell S, Simeon D, et al. Intravaginal misoprostol as a cervical ripening agent. Br J Obstet Gynaecol. 1993;100:641-644.